Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2001 AND VI 19 AND IP 8
Results: 14
1
2
Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.
- Published in:
- 2001
- By:
- Publication type:
- journal article
3
Incremental cost analysis of ambulatory clinic and home-based intravenous therapy for patients with multiple myeloma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
4
Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication.
- Published in:
- 2001
- By:
- Publication type:
- journal article
5
The cost effectiveness of stratified care in the management of migraine.
- Published in:
- 2001
- By:
- Publication type:
- journal article
6
A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings.
- Published in:
- 2001
- By:
- Publication type:
- journal article
7
Pharmacoeconomic fellowships: the need for outcome measures.
- Published in:
- 2001
- By:
- Publication type:
- journal article
8
The impact of health economics on healthcare delivery: the health economists' perspective.
- Published in:
- 2001
- By:
- Publication type:
- journal article
9
Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
10
The Burden of Arthritis and Nonsteroidal Anti-Inflammatory Treatment: A European Literature Review.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 8, p. 1, doi. 10.2165/00019053-200119001-00001
- By:
- Publication type:
- Article
11
Healthcare Resource Utilisation and Costs of Treating NSAID-Associated Gastrointestinal Toxicity: A Multinational Perspective.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 8, p. 17, doi. 10.2165/00019053-200119001-00002
- By:
- Publication type:
- Article
12
A Framework for Evaluating the Clinical Consequences of Initial Therapy with NSAIDs, NSAIDs plus Gastroprotective Agents, or Celecoxib in the Treatment of Arthritis.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 8, p. 33, doi. 10.2165/00019053-200119001-00003
- By:
- Publication type:
- Article
13
An Economic Model for Determining the Costs and Consequences of Using Various Treatment Alternatives for the Management of Arthritis in Canada.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 8, p. 49, doi. 10.2165/00019053-200119001-00004
- By:
- Publication type:
- Article
14
Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in Switzerland.
- Published in:
- PharmacoEconomics, 2001, v. 19, n. 8, p. 59, doi. 10.2165/00019053-200119001-00005
- By:
- Publication type:
- Article